Cost-effectiveness of adjuvant FOLFOX and 5FU/LV chemotherapy for patients with stage II colon cancer

Mehmet U.S. Ayvaci, Jinghua Shi, Oguzhan Alagoz*, Sam J. Lubner

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Cost-effectiveness of adjuvant FOLFOX and 5FU/LV chemotherapy for patients with stage II colon cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences